Lichtwer Pharma to modify Ginsai print ad superiority claims -- NAD.
This article was originally published in The Tan Sheet
Executive Summary
LICHTWER PHARMA WILL CLARIFY GINSAI "BETTER GINSENG" CLAIM so that future advertising "more clearly communicates the reasons why we believe `Ginsai' is a `better ginseng'" following a review by the National Advertising Division of the Council of Better Business Bureaus. NAD determined that superiority claims for Lichtwer Pharma's standardized ginseng extract are unsubstantiated, and recommended that they be modified to state the limit or basis of the claims.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning